ArticleCureus2026
Diabetic Ketoacidosis Presenting With New-Onset Generalized Tonic-Clonic Seizures and Status Epilepticus in a Previously Undiagnosed Diabetic Patient: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We present the case of a 47-year-old Moroccan male with no known history of diabetes who presented with new-onset status epilepticus. His family reported a one-year history of increasing lethargy, polyuria, polydipsia, significant weight loss, and polyphagia. Initial laboratory investigations revealed severe hyperglycemia (547 mg/dL), marked ketosis, and profound metabolic acidosis (bicarbonate level of 9 mmol/L), confirming the diagnosis of severe diabetic ketoacidosis. Further investigations, including an elevated HbA1c level (15.2%), positive anti-glutamic acid decarboxylase (GAD) antibodies (280 IU/mL), and a low fasting C-peptide level (0.06 ng/mL), supported the diagnosis of new-onset latent autoimmune diabetes in adults. Neuroimaging and electroencephalography ruled out other neurological etiologies, supporting diabetic ketoacidosis-induced status epilepticus as the most likely cause. Status epilepticus as the initial manifestation of diabetic ketoacidosis secondary to latent autoimmune diabetes in adults is rare and clinically challenging. Treatment consisted of intravenous fluids, regular insulin, and phenobarbital for seizure control, leading to progressive clinical and biochemical improvement. This case highlights the importance of early metabolic evaluation in adults presenting with new-onset seizures, even in the absence of previously known diabetes, to allow timely diagnosis and prevent severe neurological complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.